share_log

Tivic Health Systems (NASDAQ:TIVC) Vs. Medtronic (NYSE:MDT) Head-To-Head Contrast

Financial News Live ·  Jan 28, 2023 19:21

Medtronic (NYSE:MDT – Get Rating) and Tivic Health Systems (NASDAQ:TIVC – Get Rating) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, risk, earnings, profitability, analyst recommendations, dividends and valuation.

Valuation and Earnings

This table compares Medtronic and Tivic Health Systems' gross revenue, earnings per share (EPS) and valuation.

Get Medtronic alerts:
Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Medtronic $31.69 billion 3.47 $5.04 billion $3.22 25.65
Tivic Health Systems $1.17 million 6.12 -$8.49 million N/A N/A

Medtronic has higher revenue and earnings than Tivic Health Systems.

Risk and Volatility

Medtronic has a beta of 0.72, indicating that its share price is 28% less volatile than the S&P 500. Comparatively, Tivic Health Systems has a beta of 1.87, indicating that its share price is 87% more volatile than the S&P 500.

Insider and Institutional Ownership

80.4% of Medtronic shares are held by institutional investors. Comparatively, 0.2% of Tivic Health Systems shares are held by institutional investors. 0.3% of Medtronic shares are held by company insiders. Comparatively, 14.6% of Tivic Health Systems shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Profitability

This table compares Medtronic and Tivic Health Systems' net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Medtronic 14.03% 13.52% 7.77%
Tivic Health Systems -668.17% -120.72% -98.51%

Analyst Recommendations

This is a summary of recent ratings for Medtronic and Tivic Health Systems, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Medtronic 1 14 5 0 2.20
Tivic Health Systems 0 0 0 0 N/A

Medtronic presently has a consensus target price of $94.25, suggesting a potential upside of 14.13%. Given Medtronic's higher probable upside, analysts plainly believe Medtronic is more favorable than Tivic Health Systems.

Summary

Medtronic beats Tivic Health Systems on 8 of the 11 factors compared between the two stocks.

About Medtronic

(Get Rating)

Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiovascular Porrtfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment includes products for the diagnosis, treatment, and management of cardiac rhythm disorders and cardiovascular disease. The Neuroscience Portfolio is made up of cranial and spinal technologies, specialty therapies, and neuromodulation divisions. The Medical Surgical Portfolio is comprised of surgical innovations and respiratory, gastrointestinal, and renal divisions. The Diabetes Group segment offers insulin pumps, continuous glucose monitoring systems, and insulin pump consumables. The company was founded in 1949 and is headquartered in Dublin, Ireland.

About Tivic Health Systems

(Get Rating)

Tivic Health Systems Inc. operates as a bioelectronic device company that delivers non-invasive neuromodulation products for the treatment of inflammatory conditions. Its primary product is ClearUP, is a medical device intended to relieve sinus and nasal inflammation. The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S. online retailers, including BestBuy.com and FSAStore.com. Tivic Health Systems, Inc. was incorporated in 2016 and is headquartered in Hayward, California.

Receive News & Ratings for Medtronic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medtronic and related companies with MarketBeat.com's FREE daily email newsletter.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment